Special Issue "Microfluidic-Based Point-of-Care Technologies for Disease Detection and Monitoring"

A special issue of Biosensors (ISSN 2079-6374). This special issue belongs to the section "Nano- and Micro-Technologies in Biosensors".

Deadline for manuscript submissions: 31 January 2024 | Viewed by 1349

Special Issue Editor

Departments of Surgery and Immunology, Microbiome Program, Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA
Interests: microfluidics; digital microfluidics; immunoassay; single cell sequencing; bacterial DNA detection; microsensors

Special Issue Information

Dear Colleagues,

We are pleased to invite contributions to this Special Issue focusing on microfluidic-based point-of-care technologies for disease diagnosis, screening and monitoring. This Special Issue will report the latest advances in microfluidic technologies that can potentially be used for the rapid detection of critical disease biomarkers with minimal training.

The advance of microfluidics for point-of-care diagnostic platforms requires a broad range of knowledge and expertise from physics, chemistry, biology, as well as electrical, mechanical, chemical, material and biomedical engineering. Therefore, we invite contributions to this Special Issue from a broad community. We are particularly interested in works that focus on the development of novel methods for rapid, real-time biomarker detection, system miniaturization and the integration of novel technological components into microfluidic platforms for point-of-care applications.

We look forward to scientifically sound work presented in clear, concise and logical writing. The work should be thoughtfully analyzed and written for the diverse microfluidics community.

Dr. Yuguang Liu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biosensors is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • microfluidics
  • diagnostic assay
  • real-time detection
  • point-of-care
  • microsensing
  • system miniaturization

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

27 pages, 4314 KiB  
Review
Current Status and Emerging Trends in Colorectal Cancer Screening and Diagnostics
Biosensors 2023, 13(10), 926; https://doi.org/10.3390/bios13100926 - 13 Oct 2023
Viewed by 1093
Abstract
Colorectal cancer (CRC) is a prevalent and potentially fatal disease categorized based on its high incidences and mortality rates, which raised the need for effective diagnostic strategies for the early detection and management of CRC. While there are several conventional cancer diagnostics available, [...] Read more.
Colorectal cancer (CRC) is a prevalent and potentially fatal disease categorized based on its high incidences and mortality rates, which raised the need for effective diagnostic strategies for the early detection and management of CRC. While there are several conventional cancer diagnostics available, they have certain limitations that hinder their effectiveness. Significant research efforts are currently being dedicated to elucidating novel methodologies that aim at comprehending the intricate molecular mechanism that underlies CRC. Recently, microfluidic diagnostics have emerged as a pivotal solution, offering non-invasive approaches to real-time monitoring of disease progression and treatment response. Microfluidic devices enable the integration of multiple sample preparation steps into a single platform, which speeds up processing and improves sensitivity. Such advancements in diagnostic technologies hold immense promise for revolutionizing the field of CRC diagnosis and enabling efficient detection and monitoring strategies. This article elucidates several of the latest developments in microfluidic technology for CRC diagnostics. In addition to the advancements in microfluidic technology for CRC diagnostics, the integration of artificial intelligence (AI) holds great promise for further enhancing diagnostic capabilities. Advancements in microfluidic systems and AI-driven approaches can revolutionize colorectal cancer diagnostics, offering accurate, efficient, and personalized strategies to improve patient outcomes and transform cancer management. Full article
Show Figures

Figure 1

Back to TopTop